About Neumarker Inc.
Neumarker is a company focused on developing AI-powered brain biomarkers to improve the diagnosis and treatment of central nervous system (CNS) diseases. The company aims to transform neuropsychiatric care through advanced technology and multidisciplinary expertise.
Development of AI-powered brain biomarkersSupport for mental health clinicians and CNS drug developersAnalysis of complex brain functions using machine learningAddressing unmet medical needs in CNS disorders
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to Neumarker Inc. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.